Skip Nav Destination
Issues
ARTICLE
Transforming Growth Factor β Mimetics: Discovery of 7-[4-(4-Cyanophenyl) phenoxy]-Heptanohydroxamic Acid, a Biaryl Hydroxamate Inhibitor of Histone Deacetylase
Keith B. Glaser; Junling Li; Mary E. Aakre; Douglas W. Morgan; George Sheppard; Kent D. Stewart; Jennifer Pollock; Paul Lee; Chad Z. O’Connor; Steven N. Anderson; Donna J. Mussatto; Craig W. Wegner; Harold L. Moses
Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells1
Carlos Pipaón; Pilar Gutierrez; Juan Carlos Montero; Mariluz Lorenzo; Ana Eguiraun; Jesús A. De la Fuente; Atanasio Pandiella; Javier León; José M. Ortiz
Cisplatin Potentiates 1,25-Dihydroxyvitamin D3-induced Apoptosis in Association with Increased Mitogen-activated Protein Kinase Kinase Kinase 1 (MEKK-1) Expression 1
Pamela A. Hershberger; Terence F. McGuire; Wei-Dong Yu; Eleanor G. Zuhowski; Jan H. M. Schellens; Merrill J. Egorin; Donald L. Trump; Candace S. Johnson
Enterolactone Inhibits the Growth of 7,12-Dimethylbenz(a) anthracene-induced Mammary Carcinomas in the Rat 1
Niina M. Saarinen; Riikka Huovinen; Anni Wärri; Sari I. Mäkelä; Liza Valentín-Blasini; Rainer Sjöholm; Jenni Ämmälä; Reko Lehtilä; Christer Eckerman; Yrjö U. Collan; Risto S. Santti
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.